DE3413341A1 - Antikoerper fuer prostatakrebs beim menschen - Google Patents

Antikoerper fuer prostatakrebs beim menschen

Info

Publication number
DE3413341A1
DE3413341A1 DE19843413341 DE3413341A DE3413341A1 DE 3413341 A1 DE3413341 A1 DE 3413341A1 DE 19843413341 DE19843413341 DE 19843413341 DE 3413341 A DE3413341 A DE 3413341A DE 3413341 A1 DE3413341 A1 DE 3413341A1
Authority
DE
Germany
Prior art keywords
cell
antibody
prostate cancer
hybrid
human prostate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19843413341
Other languages
German (de)
English (en)
Inventor
Tomoko Nagareyama Chiba Chiku
Takayoshi Tokio/Tokyo Fujii
Eiji Inoguchi
Yosuhiko Tokio/Tokyo Kobayashi
Kenichi Matsunaga
Kenichi Saito
Chikao Kunitachi Tokio/Tokyo Yoshikumi
Makoto Yoshimura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kureha Corp
Original Assignee
Kureha Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP58061917A external-priority patent/JPS59187796A/ja
Priority claimed from JP58061919A external-priority patent/JPS59188557A/ja
Priority claimed from JP6192283A external-priority patent/JPS59186923A/ja
Application filed by Kureha Corp filed Critical Kureha Corp
Publication of DE3413341A1 publication Critical patent/DE3413341A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57525—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the liver or pancreas
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3069—Reproductive system, e.g. ovaria, uterus, testes, prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Reproductive Health (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gynecology & Obstetrics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE19843413341 1983-04-08 1984-04-09 Antikoerper fuer prostatakrebs beim menschen Withdrawn DE3413341A1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP58061917A JPS59187796A (ja) 1983-04-08 1983-04-08 抗ヒト前立腺癌抗体
JP58061919A JPS59188557A (ja) 1983-04-08 1983-04-08 ヒト前立腺癌の分類および同定用試薬
JP6192283A JPS59186923A (ja) 1983-04-08 1983-04-08 ヒト前立腺癌治療用薬剤

Publications (1)

Publication Number Publication Date
DE3413341A1 true DE3413341A1 (de) 1984-11-22

Family

ID=27297684

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19843413341 Withdrawn DE3413341A1 (de) 1983-04-08 1984-04-09 Antikoerper fuer prostatakrebs beim menschen

Country Status (4)

Country Link
DE (1) DE3413341A1 (cg-RX-API-DMAC7.html)
FR (1) FR2551085A1 (cg-RX-API-DMAC7.html)
GB (1) GB2139645A (cg-RX-API-DMAC7.html)
SE (1) SE8401946L (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4970299A (en) * 1986-07-03 1990-11-13 Sloan-Kettering Institute For Cancer Research Monoclonal antibodies selective for prostate cancer
JPH0249596A (ja) * 1988-08-09 1990-02-19 Masamichi Ueda ヒト前立腺上皮細胞の表面に特異的に反応するモノクローナル抗体

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4486538A (en) * 1978-07-07 1984-12-04 Samuel Bogoch Detection of malignant tumor cells
WO1981001849A1 (en) * 1979-12-28 1981-07-09 Research Corp Purified human prostate antigen
US4650756A (en) * 1981-08-31 1987-03-17 Sloan Kettering Institute For Cancer Research Monoclonal antibodies to cell surface antigens of human renal cancer
NO169947C (no) * 1981-10-27 1992-08-26 Hybritech Inc Fremgangsmaate for fremstilling av et monoklonalt antistoff til et tumorassosiert antigen
GB2121417A (en) * 1982-02-22 1983-12-21 Carlton Med Prod Antigens and antibodies useful in the detection of cancer
DE3211356A1 (de) * 1982-03-27 1983-09-29 Behringwerke Ag, 3550 Marburg Zell-hybrid, verfahren zu seiner herstellung sowie seine verwendung

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
Eur. J. Imnunol. 6, 292-295, 1976
J.Imnunology 123, 1548-50, 1979
KÖHLER, G., MILSTEIN, C.: Nature Vol. 256, 1975, 495-497
Monoclonal Antibodies ed by R.H. Kennett, T.J. Mekearn, K.B. Bechtol, Plenum Press, New York, 1980, S. 283
Nature 256, 495-497, 1975
Nature 276, 269-270, 1978
Nature 288, 488-489, 1980

Also Published As

Publication number Publication date
SE8401946D0 (sv) 1984-04-06
GB8408988D0 (en) 1984-05-16
FR2551085A1 (cg-RX-API-DMAC7.html) 1985-03-01
GB2139645A (en) 1984-11-14
SE8401946L (sv) 1984-11-13

Similar Documents

Publication Publication Date Title
AT394577B (de) Polydom, verfahren zu seiner herstellung und immunodiagnostische verfahren
DE68912232T2 (de) Konjugate zytotoxischer Arzneimittel.
DE3382764T2 (de) Humane-humane hybridomas für neoplasmen.
DE3586440T2 (de) Zur diagnose von menschlichem magen- oder brustkrebs zu verwendender monoklonaler antikoerper.
DE3883803T2 (de) Monoklonale Antikörper gegen melanoma-assoziierte Antigene, Hybridzellinien, die diese Antikörper produzieren, und ihre Verwendung.
DE69332741T2 (de) Nachweis von hypoxia
EP0584715B1 (de) Verfahren zur Isolierung und Kultivierung von transformierten Zellen sowie Verwendung dieser Zellen zur Herstellung individuumsspezifischer Antikörper
DD276165A5 (de) Verfahren zur detektion maligner zellen
DE69911322T2 (de) Monoklonaler antikörper der die oligosaccharide sialinsäure n-glycolierte galactose-glucose auf bösartige tumoren erkennt und zusammensetzungen die dieser enthalten
DE3780480T2 (de) Test fuer menschlichen brustkrebs.
DE68921374T2 (de) Monoklonaler Antikörper gegen menschliche Mangan-Superoxiddismutase, Verfahren zu dessen Herstellung, Testreagens, Kit und Testmethode unter Verwendung desselben, Verfahren zur Diagnose von menschlichem Eierstockkrebs und von Herzinfarkt.
DE3884646T2 (de) Humanes Karcinom-assoziertes Antigen und an dieses Antigen bindende Antikörper.
EP0547059B1 (de) Pankreas-elastase-1-spezifischer antikörper, ein verfahren zu seiner gewinnung und ein testkit der solche antikörper enthält
DE69015230T2 (de) Antikörper gegen menschliches Sperma, ihre Herstellung und Anwendung.
DE3688638T2 (de) Monoklonale Antikörper für humane Lungenkarzinome des "Nicht-kleine-Zellen"-Typs.
DE69222909T2 (de) Monoklonaler Antikörper gegen ein Synaptophysin
DE3413339A1 (de) Gegen pilze der gattung candida gerichtete antikoerper
DE3413341A1 (de) Antikoerper fuer prostatakrebs beim menschen
DE68921282T2 (de) Verfahren zur Herstellung von Human-Human-Hybridomen, die Herstellung monoklonaler bzw. polyklonaler Antikörper davon und therapeutische Verwendung davon.
DE3413340A1 (de) Antikoerper fuer harnblasenkrebs beim menschen
DE3413342A1 (de) Gegen pilze der gattung aspergillus gerichtete antikoerper
DE3785795T2 (de) Monoklonale anti-menschliche magenkrebs-antikoerper.
AT395017B (de) Verfahren zur herstellung eines neuen lymphokins (lk 2) sowie verwendung von lk 2 zur herstellung eines pharmazeutischen praeparates
DE69321454T2 (de) Zytodiagnostisches verfahren unter verwendung von alstonin als selektivem marker und diesen marker enthaltender diagnostischer kit
DE68926245T2 (de) Nachweis der basismembrankomponenten, diagnose von krebs und sonstigen krankheiten

Legal Events

Date Code Title Description
OP8 Request for examination as to paragraph 44 patent law
8172 Supplementary division/partition in:

Ref country code: DE

Ref document number: 3448019

Format of ref document f/p: P

Q171 Divided out to:

Ref country code: DE

Ref document number: 3448019

8172 Supplementary division/partition in:

Ref country code: DE

Ref document number: 3448018

Format of ref document f/p: P

Q171 Divided out to:

Ref country code: DE

Ref document number: 3448018

8128 New person/name/address of the agent

Representative=s name: KADOR, U., DIPL.-CHEM. DR.RER.NAT., PAT.-ANW., 800

8139 Disposal/non-payment of the annual fee